Clinical trial
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
NCT03449758
Study timeline
Study start (actual)2018-03-05Date precision: day
Registry last updated2022-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
SARILUMABDRUG · verified · RxNorm: sarilumab
AzathioprineDRUG · verified · RxNorm: azathioprine
ChloroquineDRUG · verified · RxNorm: chloroquine
HydroxychloroquineDRUG · verified · RxNorm: hydroxychloroquine
LeflunomideDRUG · verified · RxNorm: leflunomide
MethotrexateDRUG · verified · RxNorm: methotrexate
SulfasalazineDRUG · verified · RxNorm: sulfasalazine
Sponsors & collaborators
Sanofilead sponsor
Regeneron Pharmaceuticalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03449758 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.